Chang Mineok, Lee Cheol Whan, Ahn Jung-Min, Cavalcante Rafael, Sotomi Yohei, Onuma Yoshinobu, Park Duk-Woo, Kang Soo-Jin, Lee Seung-Whan, Kim Young-Hak, Park Seong-Wook, Serruys Patrick W, Park Seung-Jung
Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
Heart Institute, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
J Am Geriatr Soc. 2017 Mar;65(3):625-630. doi: 10.1111/jgs.14780. Epub 2017 Feb 6.
Little data are available to compare coronary artery bypass graft surgery (CABG) vs percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in older adults. We evaluate the long-term outcomes of CABG vs PCI with DES in older adults with left main or multivessel coronary artery disease (CAD).
Individual patient-level meta-analysis.
Databases from the BEST, PRECOMBAT, and SYNTAX trials were combined.
A total 1,079 adults aged 70 to 89 years were pooled.
The primary outcome was a composite of death from any causes, myocardial infarction, stroke, or repeat revascularization.
During a total of 6.3 (median, 4.9) years of follow-up, the primary composite outcome of all-cause mortality, myocardial infarction, stroke, or repeat revascularization occurred in 26% (141/550) and 34% (179/529) of patients in the CABG and PCI groups, respectively (hazard ratio (HR), 0.75; 95% confidence interval (CI), 0.60-0.94; P = .012). CABG was associated with fewer myocardial infarction (4% vs 8% for PCI; HR, 0.48; 95% CI, 0.29-0.80; P = .037); and repeat revascularizations (8% vs 17% for PCI; HR, 044; 95% CI, 0.31-0.64; P < .001), but had little association with all-cause mortality or stroke.
Older adults age 70 to 89 years with left main or multivessel CAD who participated in the BEST, PRECOMBAT, and SYNTAX trials; compared to PCI, CABG was associated with lower risk of primary outcome which was mostly driven by lower risk of myocardial infarction.
在老年人中,可用于比较冠状动脉旁路移植术(CABG)与药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI)的数据很少。我们评估了患有左主干或多支冠状动脉疾病(CAD)的老年人中CABG与DES-PCI的长期结局。
个体患者水平的荟萃分析。
合并了来自BEST、PRECOMBAT和SYNTAX试验的数据库。
总共纳入了1079名年龄在70至89岁之间的成年人。
主要结局是全因死亡、心肌梗死、中风或再次血运重建的复合结局。
在总共6.3年(中位数为4.9年)的随访期间,CABG组和PCI组中分别有26%(141/550)和34%(179/529)的患者发生了全因死亡、心肌梗死、中风或再次血运重建的主要复合结局(风险比(HR)为0.75;95%置信区间(CI)为0.60-0.94;P = 0.012)。CABG与较少的心肌梗死(PCI为4%,CABG为8%;HR为0.48;95%CI为0.29-0.80;P = 0.037)以及再次血运重建(PCI为17%,CABG为8%;HR为0.44;95%CI为0.31-0.64;P < 0.001)相关,但与全因死亡率或中风关联不大。
参与BEST、PRECOMBAT和SYNTAX试验的70至89岁患有左主干或多支CAD的老年人;与PCI相比,CABG的主要结局风险较低,这主要是由较低的心肌梗死风险驱动的。